CD4 and myasthenia gravis: Accordingly, when using a cutoff of >2.0 for the comparison between DC:TC co-cultures and PBMC cultures, we found that 7/7 MG patients responded with CD4+ T cell AChR-peptide recognition while only 4/7 patients responded using the conventional PBMC culture.